Clinical Trial

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease

Study acronym: RELAX
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 3, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Children with sickle cell disease may experience frequent painful episodes. This, together with the traumatic experiences during a hospitalization, can lead to the development of posttraumatic stress reactions. As the stress can trigger painful episodes (pain crisis) in children with sickle cell disease, the investigators think that treating these stress symptoms can reduce the pain-related problems in their lives. Eye Movement Desensitization and Reprocessing (EMDR) is proven to be an effective trauma treatment for posttraumatic stress disorder. Research studies show that EMDR can reduce pain in adults. The investigators want to study now if EMDR effective is in reducing pain-related problems in children with sickle cell disease.
Trial Details
NCT Number NCT07001631
Lead Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions Sickle Cell Disease, Pain, Pain, Chronic Disease
Enrollment 40 participants
Start Date 2024-09-20
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-03